VASO Corp's Net Loss Widens Amid Rising Operating Costs

TL;DR

**VASO's widening net loss and ballooning operating expenses make it a risky bet, despite a slight revenue bump; steer clear until they prove profitability.**

AI Summary

VASO Corp reported a net loss of $1.272 million for the six months ended June 30, 2025, a significant decline from a net loss of $18,000 in the same period of 2024. Total revenues increased slightly to $39.418 million for the six months ended June 30, 2025, up from $38.963 million in 2024, representing a 1.17% increase. This was primarily driven by a 2.39% increase in managed IT systems and services revenue to $20.999 million and a 1.23% increase in professional sales services revenue to $17.449 million. However, equipment sales and services revenue decreased by 1.32% to $970,000. The company's operating loss widened to $1.639 million for the six months ended June 30, 2025, compared to an operating loss of $473,000 in the prior year, largely due to a 6.73% increase in selling, general and administrative expenses to $24.449 million. Cash and cash equivalents increased to $32.560 million at June 30, 2025, from $26.271 million at December 31, 2024, primarily due to $6.229 million in net cash provided by operating activities. The termination of the business combination agreement with Achari Ventures Holdings Corp. I, as disclosed, eliminated associated transaction costs in the current period.

Why It Matters

VASO Corp's widening net loss and increased operating expenses signal potential challenges for investors, despite a slight revenue increase. The company's ability to convert its growing deferred revenue of $38.112 million into profit will be crucial for future performance and investor confidence. For employees, the focus on managed IT and professional sales services suggests stability in those segments, but the overall financial performance could impact future growth opportunities. Customers might see continued investment in IT and sales services, but the declining equipment sales segment could indicate shifts in product focus or market demand, potentially affecting product availability or support in that area. In a competitive healthcare IT and medical device market, VASO's struggle with profitability could make it harder to compete with larger, more financially robust players.

Risk Assessment

Risk Level: high — VASO Corp reported a net loss of $1.272 million for the six months ended June 30, 2025, a significant increase from a net loss of $18,000 in the prior year. This is compounded by a substantial operating loss of $1.639 million for the same period, up from $473,000, driven by a 6.73% increase in selling, general and administrative expenses to $24.449 million, indicating a struggle with cost control and profitability.

Analyst Insight

Investors should exercise caution and closely monitor VASO Corp's next earnings reports for signs of improved cost management and a return to profitability. Consider holding off on new investments until there's clear evidence of a reversal in the negative net income trend and a reduction in operating losses.

Financial Highlights

debt To Equity

N/A

revenue

$39.418M

operating Margin

N/A

total Assets

$82.582M

total Debt

N/A

net Income

-$1.272M

eps

N/A

gross Margin

N/A

cash Position

$32.560M

revenue Growth

+1.17%

Revenue Breakdown

Key Numbers

• $1.272M — Net Loss (for the six months ended June 30, 2025, compared to $18,000 net loss in 2024)
• $39.418M — Total Revenues (for the six months ended June 30, 2025, up from $38.963 million in 2024)
• $1.639M — Operating Loss (for the six months ended June 30, 2025, compared to $473,000 operating loss in 2024)
• $24.449M — Selling, General and Administrative Expenses (for the six months ended June 30, 2025, up from $22.907 million in 2024)
• $32.560M — Cash and Cash Equivalents (at June 30, 2025, up from $26.271 million at December 31, 2024)
• $6.229M — Net Cash Provided by Operating Activities (for the six months ended June 30, 2025, up from $1.718 million in 2024)
• $108M — Unfulfilled Performance Obligations (as of June 30, 2025, representing future revenue recognition)
• 175,753,035 — Common Shares Outstanding (at August 12, 2025)

Key Players & Entities

• VASO Corp (company) — registrant
• Achari Ventures Holdings Corp. I (company) — terminated business combination partner
• VasoTechnology, Inc. (company) — wholly-owned IT segment subsidiary
• Vaso Diagnostics, Inc. d/b/a VasoHealthcare (company) — wholly-owned professional sales service segment subsidiary
• VasoMedical, Inc. (company) — wholly-owned equipment segment subsidiary
• GE Healthcare Technologies, Inc. (company) — exclusive sales representation agreement partner
• SEC (regulator) — Securities and Exchange Commission
• Bloomberg (company) — financial news organization

FAQ

Risk Factors

• Widening Operating Loss [high — financial]: The company reported an operating loss of $1.639 million for the six months ended June 30, 2025, a significant increase from $473,000 in the prior year. This widening loss is primarily driven by a 6.73% increase in selling, general and administrative expenses to $24.449 million, indicating potential inefficiencies or increased operational costs that are not being offset by revenue growth.
• Net Loss Deterioration [high — financial]: VASO Corp incurred a net loss of $1.272 million for the six months ended June 30, 2025, a substantial worsening from a net loss of $18,000 in the same period of 2024. This indicates a significant decline in profitability, raising concerns about the company's ability to generate sustainable earnings.
• Dependence on IT Services [medium — operational]: While Managed IT systems and services revenue grew by 2.39% to $20.999 million, this segment, along with professional sales services, forms the bulk of the company's revenue. A slowdown or disruption in these core service areas could materially impact overall financial performance.
• Declining Equipment Sales [low — financial]: Equipment sales and services revenue decreased by 1.32% to $970,000. This segment, though small, represents a potential area of concern if it signals a broader market shift away from the company's offerings or increased competition.
• Termination of Business Combination Agreement [medium — legal]: The termination of the business combination agreement with Achari Ventures Holdings Corp. I, while eliminating associated transaction costs in the current period, may indicate underlying issues with strategic partnerships or M&A activities, potentially impacting future growth strategies.

Industry Context

VASO Corp operates in the IT services sector, which is characterized by rapid technological advancements and increasing demand for outsourced IT management. The competitive landscape includes a wide range of providers, from large global firms to specialized local companies. Trends include a growing emphasis on cloud computing, cybersecurity, and data analytics, requiring continuous investment in talent and technology.

Regulatory Implications

As a publicly traded company, VASO Corp is subject to SEC regulations and reporting requirements. The company must ensure compliance with accounting standards (GAAP) and maintain effective internal controls over financial reporting. Any misstatements or control deficiencies could lead to regulatory scrutiny and penalties.

What Investors Should Do

1. Monitor SG&A Expense Growth
2. Analyze Revenue Mix and Growth Drivers
3. Evaluate Path to Profitability
4. Assess Cash Burn Rate and Runway

Key Dates

• 2025-06-30: Six Months Ended — Reporting period for the current 10-Q, showing a net loss of $1.272 million and an operating loss of $1.639 million.
• 2024-06-30: Six Months Ended — Prior year comparable period, showing a net loss of $18,000 and an operating loss of $473,000, highlighting a significant deterioration in performance.
• 2025-12-31: Year End — Previous reporting period for cash and cash equivalents, which stood at $26.271 million.

Glossary

Managed IT systems and services

Services provided by a third party to manage and maintain a client's information technology systems. (A primary revenue driver for VASO Corp, showing modest growth.)

Professional sales services

Services related to the sales process, potentially including lead generation, sales support, and customer relationship management. (Another key revenue segment for VASO Corp, also showing slight growth.)

Selling, general and administrative expenses (SG&A)

Costs incurred by a company in the process of selling, marketing, and delivering its products or services, as well as general overhead costs. (An area of concern as SG&A increased by 6.73% to $24.449 million, contributing to the widened operating loss.)

Unfulfilled Performance Obligations

Represents the total value of services or goods that a company has contracted to provide to customers but has not yet delivered or recognized as revenue. (Indicates future revenue potential, with $108 million as of June 30, 2025.)

Accumulated deficit

The cumulative net losses of a company since its inception, less any cumulative net income. (VASO Corp has an accumulated deficit of $35.353 million as of June 30, 2025, indicating historical unprofitability.)

Year-Over-Year Comparison

Compared to the prior year's six-month period, VASO Corp has experienced a significant deterioration in profitability, with net losses widening from $18,000 to $1.272 million and operating losses increasing from $473,000 to $1.639 million. This is largely attributable to a 6.73% increase in selling, general and administrative expenses, which outpaced the modest 1.17% growth in total revenues. While cash reserves have increased due to positive operating cash flow, the declining profitability presents a key concern for investors.

Filing Documents

• ea0251968-10q_vasocorp.htm (10-Q) — 778KB
• ea025196801ex31-1_vasocorp.htm (EX-31.1) — 9KB
• ea025196801ex31-2_vasocorp.htm (EX-31.2) — 9KB
• ea025196801ex32-1_vasocorp.htm (EX-32.1) — 3KB
• ea025196801ex32-2_vasocorp.htm (EX-32.2) — 3KB
• image_001.jpg (GRAPHIC) — 3KB
• 0001213900-25-076616.txt ( ) — 5023KB
• vaso-20250630.xsd (EX-101.SCH) — 44KB
• vaso-20250630_cal.xml (EX-101.CAL) — 50KB
• vaso-20250630_def.xml (EX-101.DEF) — 187KB
• vaso-20250630_lab.xml (EX-101.LAB) — 362KB
• vaso-20250630_pre.xml (EX-101.PRE) — 214KB
• ea0251968-10q_vasocorp_htm.xml (XML) — 735KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 1

- FINANCIAL STATEMENTS

ITEM 1 - FINANCIAL STATEMENTS 1 CONDENSED CONSOLIDATED BALANCE SHEETS as of June 30, 2025 (unaudited) and December 31, 2024 1 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (unaudited) for the Three and Six Months Ended June 30, 2025 and 2024 2 CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) for the Three and Six Months Ended June 30, 2025 and 2024 3 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) for the Six Months Ended June 30, 2025 and 2024 4 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) 5

- MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 18 ITEM 3. Quantitative and Qualitative Disclosures About Market Risk. 25 ITEM 4 - CONTROLS AND PROCEDURES 26

- OTHER INFORMATION

PART II - OTHER INFORMATION 27 ITEM 1 – LEGAL PROCEEDINGS 27

Risk Factors

ITEM 1A. Risk Factors 27

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 27

Defaults Upon Senior Securities

ITEM 3. Defaults Upon Senior Securities 27

Mine Safety Disclosures

ITEM 4. Mine Safety Disclosures 27

Other Information

ITEM 5. Other Information 27

– EXHIBITS

ITEM 6 – EXHIBITS 27 i

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

- FINANCIAL STATEMENTS

ITEM 1 - FINANCIAL STATEMENTS Vaso Corporation and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) June 30, 2025 December 31, 2024 (unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 32,560 $ 26,271 Accounts and other receivables, net of an allowance for credit losses and commission adjustments of $ 11,332 at June 30, 2025 and $ 10,708 at December 31, 2024 8,831 16,999 Receivables due from related parties 1,109 943 Inventories, net 939 911 Deferred commission expense 3,546 3,659 Prepaid expenses and other current assets 2,987 2,402 Total current assets 49,972 51,185 Property and equipment, net of accumulated depreciation of $ 10,932 at June 30, 2025 and $ 10,712 at December 31, 2024 1,848 1,544 Operating lease right of use assets 1,969 2,345 Goodwill 15,572 15,551 Intangibles, net 1,825 1,615 Other assets, net 6,059 5,358 Investment in EECP Global 433 436 Deferred tax assets, net 4,904 4,904 Total assets $ 82,582 $ 82,938 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 4,740 $ 4,179 Accrued commissions 1,261 3,256 Accrued expenses and other liabilities 6,447 8,251 Finance lease liabilities - current - 24 Operating lease liabilities - current 1,082 1,067 Sales tax payable 743 802 Income taxes payable 5 60 Deferred revenue - current portion 17,762 17,072 Notes payable - current portion 978 6 Due to related party 3 3 Total current liabilities 33,021 34,720 LONG-TERM LIABILITIES Operating lease liabilities, net of current portion 888 1,278 Deferred revenue, net of current portion 20,350 17,822 Other long-term liabilities 1,822 1,416 Total long-term liabilities 23,060 20,516 COMMITMENTS AND CONTINGENCIES (NOTE O) STOCKHOLDERS' EQUITY Preferred stock, $ .01 par value; 1,000,000 shares authorized; nil shares issued and outstanding at June

View Full Filing

View this 10-Q filing on SEC EDGAR